Thioredoxin reductase inhibition elicits Nrf2-mediated responses in clara cells: Implications for oxidant-induced lung injury

Antioxidants and Redox Signaling

Volumn 17, Issue 10, 2012, Pages 1407-1416

  Locy, Morgan L ^a   Rogers, Lynette K ^a,b   Prigge, Justin R ^c   Schmidt, Edward E ^c   J Arnér, Elias S ^d   Tipple, Trent E ^b  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c MONTANA STATE UNIVERSITY   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AUROTHIOGLUCOSE; GLUTATHIONE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); SMALL INTERFERING RNA; THIOREDOXIN REDUCTASE; TRANSCRIPTION FACTOR NRF2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CLARA CELL; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN TISSUE; HYPEROXIA; IN VITRO STUDY; IN VIVO STUDY; INFANT; LUNG INJURY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SINGLE DRUG DOSE;

ANIMALS; AUROTHIOGLUCOSE; HUMANS; LUNG INJURY; MICE; NAD(P)H DEHYDROGENASE (QUINONE); NF-E2-RELATED FACTOR 2; OXIDANTS; THIOREDOXIN-DISULFIDE REDUCTASE;

MURINAE; MUS;

EID: 84866283134     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2011.4377     Document Type: Article

References (40)

1. Arner ES. Focus on mammalian thioredoxin reductases-important selenoproteins with versatile functions. Biochim Biophys Acta 1790: 495-526, 2009.
2. Arner ES and Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem 267: 6102-6109, 2000.
3. Auten RL and Davis JM. Oxygen toxicity and reactive oxygen species: the devil is in the details. Pediatr Res 66: 121-127, 2009.
4. Awasthi YC, Sharma R, and Singhal SS. Human glutathione S-transferases. Int J Biochem 26: 295-308, 1994.
5. Barrios R, Shi ZZ, Kala SV, Wiseman AL, Welty SE, Kala G, Bahler AA, Ou CN, and Lieberman MW. Oxygen-induced pulmonary injury in gamma-glutamyl transpeptidasedeficient mice. Lung 179: 319-330, 2001. (Pubitemid 34442217)
6. Cenas N, Prast S, Nivinskas H, Sarlauskas J, and Arner ES. Interactions of nitroaromatic compounds with the mammalian selenoprotein thioredoxin reductase and the relation to induction of apoptosis in human cancer cells. J Biol Chem 281: 5593-5603, 2006. (Pubitemid 43847656)
7. Cho HY, Jedlicka AE, Reddy SP, Kensler TW, Yamamoto M, Zhang LY, and Kleeberger SR. Role of NRF2 in protection against hyperoxic lung injury in mice. Am J Respir Cell Mol Biol 26: 175-182, 2002. (Pubitemid 34107870)
8. Cho HY, Jedlicka AE, Reddy SP, Zhang LY, Kensler TW, and Kleeberger SR. Linkage analysis of susceptibility to hyperoxia. Nrf2 is a candidate gene.AmJRespir CellMol Biol 26: 42-51, 2002. (Pubitemid 34029819)
9. Crapo JD. Morphologic changes in pulmonary oxygen toxicity. Annu Rev Physiol 48: 721-731, 1986. (Pubitemid 16047645)
10. Dammeyer P and Arner ES. Human protein atlas of redox systems-what can be learnt? Biochim Biophys Acta 1810: 111-138, 2011.
11. Dong J, Sulik KK, and Chen SY. Nrf2-mediated transcriptional induction of antioxidant response in mouse embryos exposed to ethanol in vivo: implications for the prevention of fetal alcohol spectrum disorders. Antioxid Redox Signal 10: 2023-2033, 2008.
12. Fourquet S, Guerois R, Biard D, and Toledano MB. Activation of NRF2 by nitrosative agents and H2O2 involves KEAP1 disulfide formation. J Biol Chem 285: 8463-8471, 2010.
13. Godoy JR, Funke M, Ackermann W, Haunhorst P, Oesteritz S, Capani F, Elsasser HP, and Lillig CH. Redox atlas of the mouse. Immunohistochemical detection of glutaredoxin-, peroxiredoxin-, and thioredoxin-family proteins in various tissues of the laboratory mouse. Biochim Biophys Acta 1810: 2-92, 2011.
14. Gromer S, Arscott LD, Williams CH, Jr., Schirmer RH, and Becker K. Human placenta thioredoxin reductase. Isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds. J Biol Chem 273: 20096-20101, 1998. (Pubitemid 28377564)
15. Gromer S, Merkle H, Schirmer RH, and Becker K. Human placenta thioredoxin reductase: preparation and inhibitor studies. Methods Enzymol 347: 382-394, 2002. (Pubitemid 34233291)
16. Holmgren A. Thioredoxin. Annu Rev Biochem 54: 237-271, 1985. (Pubitemid 15073647)
17. Holmgren A. Thioredoxin and glutaredoxin systems. J Biol Chem 264: 13963-13966, 1989. (Pubitemid 19214215)
18. Jurado J, Prieto-Alamo MJ, Madrid-Risquez J, and Pueyo C. Absolute gene expression patterns of thioredoxin and glutaredoxin redox systems in mouse. J Biol Chem 278: 45546-45554, 2003. (Pubitemid 37432695)
19. Kataoka K, Handa H, and Nishizawa M. Induction of cellular antioxidative stress genes through heterodimeric transcription factor Nrf2/small Maf by antirheumatic gold(I) compounds. J Biol Chem 276: 34074-34081, 2001.
20. Kensler TW, Wakabayashi N, and Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 47: 89-116, 2007.
21. Khouzami L, Bourin MC, Christov C, Damy T, Escoubet B, Caramelle P, Perier M, Wahbi K, Meune C, Pavoine C, and Pecker F. Delayed cardiomyopathy in dystrophin deficient mdx mice relies on intrinsic glutathione resource. Am J Pathol 177: 1356-1364, 2010.
22. Kim C, Jang JS, Cho MR, Agarawal SR, and Cha YN. Taurine chloramine induces heme oxygenase-1 expression via Nrf2 activation in murine macrophages. Int Immunopharmacol 10: 440-446, 2010.
23. Kobayashi M, Nakamura H, Yodoi J, and Shiota K. Immunohistochemical localization of thioredoxin and glutaredoxin in mouse embryos and fetuses. Antioxid Redox Signal 2: 653-663, 2000. (Pubitemid 32062316)
24. Magdaleno SM, Wang G, Jackson KJ, Ray MK, Welty S, Costa RH, and DeMayo FJ. Interferon-gamma regulation of Clara cell gene expression: in vivo and in vitro. Am J Physiol 272: L1142-L1151, 1997.
25. Mandal PK, Schneider M, Kolle P, Kuhlencordt P, Forster H, Beck H, Bornkamm GW, and Conrad M. Loss of thioredoxin reductase 1 renders tumors highly susceptible to pharmacologic glutathione deprivation. Cancer Res 70: 9505-9514, 2010.
26. Marzec JM, Christie JD, Reddy SP, Jedlicka AE, Vuong H, Lanken PN, Aplenc R, Yamamoto T, Yamamoto M, Cho HY, and Kleeberger SR. Functional polymorphisms in the transcription factor NRF2 in humans increase the risk of acute lung injury. FASEB J 21: 2237-2246, 2007. (Pubitemid 47026458)
27. Meister A. Glutathione metabolism and its selective modification. J Biol Chem 263: 17205-17208, 1988. (Pubitemid 19029311)
28. Nakamura T, Nakamura H, Hoshino T, Ueda S, Wada H, and Yodoi J. Redox regulation of lung inflammation by thioredoxin. Antioxid Redox Signal 7: 60-71, 2005. (Pubitemid 40187925)
29. Nguyen T, Nioi P, and Pickett CB. The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J Biol Chem 284: 13291-13295, 2009.
30. Reddy NM, Kleeberger SR, Kensler TW, Yamamoto M, Hassoun PM, and Reddy SP. Disruption of Nrf2 impairs the resolution of hyperoxia-induced acute lung injury and inflammation in mice. J Immunol 182: 7264-7271, 2009.
31. Reddy NM, Potteti HR, Mariani TJ, Biswal S, and Reddy SP. Conditional deletion of Nrf2 in airway epithelium exacerbates acute lung injury and impairs the resolution of inflammation. Am J Respir Cell Mol Biol 45: 1161-1168, 2011.
32. Reddy NM, Suryanaraya V, Yates MS, Kleeberger SR, Hassoun PM, Yamamoto M, Liby KT, Sporn MB, Kensler TW, and Reddy SP. The triterpenoid CDDO-imidazolide confers potent protection against hyperoxic acute lung injury in mice. Am J Respir Crit Care Med 180: 867-874, 2009.
33. Rengby O, Cheng Q, Vahter M, Jornvall H, and Arner ES. Highly active dimeric and low-activity tetrameric forms of selenium-containing rat thioredoxin reductase 1. Free Radic Biol Med 46: 893-904, 2009.
34. Rhee SG, Chae HZ, and Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med 38: 1543-1552, 2005. (Pubitemid 40726061)
35. Rogers LK, Valentine CJ, Pennell M, Velten M, Britt RD, Dingess K, Zhao X, Welty SE, and Tipple TE. Maternal docosahexaenoic acid supplementation decreases lung inflammation in hyperoxia-exposed newborn mice. J Nutr 141: 214-222, 2011.
36. Soini Y, Kahlos K, Napankangas U, Kaarteenaho-Wiik R, Saily M, Koistinen P, Paaakko P, Holmgren A, and Kinnula VL. Widespread expression of thioredoxin and thioredoxin reductase in non-small cell lung carcinoma. Clin Cancer Res 7: 1750-1757, 2001. (Pubitemid 32708645)
37. Suvorova ES, Lucas O, Weisend CM, Rollins MF, Merrill GF, Capecchi MR, and Schmidt EE. Cytoprotective Nrf2 pathway is induced in chronically txnrd 1-deficient hepatocytes. PloS One 4: e6158, 2009.
38. Tipple TE, Welty SE, Rogers LK, Hansen TN, Choi YE, Kehrer JP, andSmithCV. Thioredoxin-relatedmechanisms in hyperoxic lung injury in mice. Am J Respir Cell Mol Biol 37: 405-413, 2007. (Pubitemid 47502715)
39. Yates MS, Tauchi M, Katsuoka F, Flanders KC, Liby KT, Honda T, Gribble GW, Johnson DA, Johnson JA, Burton NC, Guilarte TR, Yamamoto M, Sporn MB, and Kensler TW. Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes. Mol Cancer Therapeut 6: 154-162, 2007. (Pubitemid 46206678)
40. Yoo MH, Xu XM, Carlson BA, Gladyshev VN, and Hatfield DL. Thioredoxin reductase 1 deficiency reverses tumor phenotype and tumorigenicity of lung carcinoma cells. J Biol Chem 281: 13005-13008, 2006. (Pubitemid 43855208)